Prognostic significance of p105 (c-erbB-2, HER2/neu) serum levels in patients with ovarian cancer

Anticancer Research

Volumn 17, Issue 1 B, 1997, Pages 757-760

  Meden, Harald ^a   Marx, Dagmar ^a   Schauer, Alfred ^a   Wuttke, Wolfgang ^a   Kuhn, Walther ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

c erbB 2; HER2 neu; Oncogene; Ovarian cancer; Prognosis

Indexed keywords

CA 125 ANTIGEN; ONCOPROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; ONCOGENE C ERB; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; PROGNOSIS; RECEPTOR, ERBB-2;

EID: 0031050829     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Baselga J, Tripathy D, Mendelsohn J et al: Phase II study of recombinant human anti-HER2 monoclonal antibody (rhuMAb HER2) in stage IV breast cancer (BC): HER2-shedding dependent pharmacokinetics and antitumor activity. Proceedings of ASCO 12: 103, 1995.
2. Carney WP, Hamer PJ, Petit D, Retos C, Greene R, Zabrecky JR, McKenzie S, Hayes S, Kufe D, DeLellis R, Naber R, Wolfe H: Detection and quantification of the human neu oncoprotein. In: J Tumormarker Oncology, 6 (Lieben MA, ed). 1991, pp 53-72.
3. Kaplan E and Meier P: Non parametric estimation from incomplete Observation. J Am Stat Assoc 53: 457-481, 1958.
4. King, CR, Krauss, MH, DiFiore PP, Paik S, Kasprzyk, PG: Implications of erbB-2 overexpression for basic science and clinical medicine. Sem Cancer Biol 1: 329-338, 1990.
5. Kynast B, Binder L, Marx D, Zoll B, Schmoll HJ, Oellerich M, Schauer A: Determination of a fragment of the c-erbB-2 translational product p 185 in serum of breast cancer patients. J Cancer Res Clin Oncol 119: 249-252, 1993.
6. Leitzel K, Teramoto Y, Sampson D, Mauceri J, Langton BC, Demers L, Podczaski E, Harvey H, Shambaugh S, Volas G, Weaver S, Lipton A: Elevated soluble c-erbB-2 antigen levels in serum and effusions of a proportion of breast cancer patients. J Clin Oncol 10: 1436-1443, 1992.
7. Marx D, Schauer A, Reiche C, May A, Ummenhofer AL, Reles A, Rauschecker H, Sauer R, Sehumacher M: c-erb-2-expression in correlation to other biological parameters of breast cancer. J Cancer Res Clin Oncol 116: 15-20, 1990.
8. Meden H, Marx D, Rath W, Kron M, Fattahi-Meibodi A, Hinney B, Kuhn W, Schauer A: Overexpression of the oncogene c-erbB-2 in primary, ovarian cancer: evaluation of the prognostic value in a Cox proportional hazards multiple regression. Intern J Gynecol Pathol 13: 45-53, 1994.
9. Meden H, Marx D, Fattahi A, Rath W, Kron M, Wuttke W, Schauer A, Kuhn W: Elevated serum levels of a c-erbB-2 oncogene product in ovarian cancer patients and in pregnancy. J Cancer Res Clin Oncol 129: 378-381, 1994.
10. Moden HD, Marx H: Hammadi, A Schauer, W. Kuhn: c-erbB-2-Onkogenüberexpression beim Ovarialkarzinom-Prognostische Bedeutung und Korrelation mit klinischen Befunden bei 119 Patientinnen. Verh Dtsch Ges Path 75: 341, 1991.
11. Meden MD, Marx W, Rath W, Kuhn B, Hinney A: Schauer: c-erbB-2-Onkogenüberexpression bei primären Ovarialkarzinomen: Häufigkeit und prognostische Bedeutung bei 243 Patientinnen. Geburtsh u Frauenheilk 52: 667-673, 1992.
12. Mori S, Mori Y, Mukaiyama T, Yamada Y, Sonobe Y, Matsushita H, Sakamoto G, Akiyama T, Ogawa M, Shiraishi M, Toyshima K, Yamamoto T: In vitro and in vivo release of soluble erbB-2 protein from human carcinoma cells. Jpn J Cancer Res 81: 489-494, 1990.
13. Schechter AL, Stern DF, Vaidyanathan L, Decker SJ, Drebin JA, Greene MI, Weinberg RA: The neu oncogene: an erb-B-related gene encoding a 185.000-M tumour antigen. Nature 312: 513-516, 1984.
14. Serov SF, Scully RE, Sobin LH. Histological typing of ovarian cancer tumors. In: World Health Organization. International histological classification of tumors. Geneva: World Health Organization, 1973.
15. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL: Human breast cancer correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science (Wash DC) 235: 177-182, 1987.
16. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE et al: Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science (Wash DC) 244: 707-712, 1989.
17. Yamamoto T, Shantard I, Akiyama T, Semba K, Nomura N, Miyajima N, Saito T, Toyoshima K: An erb-B-related gene c-erbB-2 encodes a possible receptor protein similar to the epidermal growth factor receptor. Nature. 319: 230-234, 1986.
18. Zabrecky JR, Lam T, McKenzie SJ, Carney W: The extracellular domain of p185/neu is released from the surface of human breast carcinoma cells. SK-BR-3. J Biol Chemistry 266: 1716-1720, 1991.